Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5603/ARM.a2020.0199 http://scihub22266oqcxt.onion/10.5603/ARM.a2020.0199 33393657!ä!33393657 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Adv+Respir+Med 2020 ; 88 (6): 620-625 Nephropedia Template TP {{tp|p=33393657|t=2020. SARS-CoV-2 lung disease in a patient with pulmonary sarcoidosis - case report |pdf=|usr=}}{{33393657}} gab.com Text SARS-CoV-2 lung disease in a patient with pulmonary sarcoidosis - case report JO: Adv Respir Med http://www.kidney.de/pget.php?&tw=1&pmid=33393657 #FOAvip Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the recently identified cause of the current pandemic. In patients with chronic respiratory lung diseases, SARS-CoV-2 may result in significant morbidity and increased mortality. We present a case of a 69-year-old male with stage II pulmonary sarcoidosis who had been under observation for 30 months without immunosuppressive treatment. He then developed severe SARS-CoV-2 disease with typical radiological and laboratory findings. Therapy with oxygen, antibiotics, low-molecular-weight heparin in a prophylactic dose, and dexamethasone resulted in marked clinical improvement. We will discuss the rationale for corticosteroid use in both SARS-CoV-2 disease and in SARS-CoV-2 disease that is complicating comorbid sarcoidosis. Twit Text FOAVip SARS-CoV-2 lung disease in a patient with pulmonary sarcoidosis - case report ????Adv Respir Med http://www.kidney.de/pget.php?&tw=1&pmid=33393657 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33393657 #FOAvip English Wikipedia <ref>{{Cite pmid|33393657}}</ref> SARS-CoV-2 lung disease in a patient with pulmonary sarcoidosis - case report #MMPMID33393657 Opoka LM; Wyrostkiewicz D; Winek J; Blasinska K; Milkowska-Dymanowska J; Szturmowicz M Adv Respir Med 2020[]; 88 (6): 620-625 PMID33393657show ga Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the recently identified cause of the current pandemic. In patients with chronic respiratory lung diseases, SARS-CoV-2 may result in significant morbidity and increased mortality. We present a case of a 69-year-old male with stage II pulmonary sarcoidosis who had been under observation for 30 months without immunosuppressive treatment. He then developed severe SARS-CoV-2 disease with typical radiological and laboratory findings. Therapy with oxygen, antibiotics, low-molecular-weight heparin in a prophylactic dose, and dexamethasone resulted in marked clinical improvement. We will discuss the rationale for corticosteroid use in both SARS-CoV-2 disease and in SARS-CoV-2 disease that is complicating comorbid sarcoidosis. |Aged[MESH] |Anti-Bacterial Agents/therapeutic use[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19/*complications/*therapy[MESH] |Critical Care/methods[MESH] |Heparin, Low-Molecular-Weight/therapeutic use[MESH] |Humans[MESH] |Hyperbaric Oxygenation/methods[MESH] |Male[MESH]SARS-CoV-2 lung disease in a patient with pulmonary sarcoidosis - case(epmc).pdf DeepDyve Pubget Overpricing